Product Information

NAPROXEN SODIUM 275 MG TAB is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.2022 per EA under NDC 50228043205. Its NADAC has been published 163 times since Sep 9, 2020.

FDA first approved this application on Oct 30, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NAPROXEN SODIUM 275 MG TAB

Naproxen Sodium
$0.2022per EA

Strength

275 mg/1

NDC

50228043205

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NAPROXEN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA212199

FDA Approved

10/30/2019

TE Code

AB

On Market Since

10/30/2019

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for NAPROXEN SODIUM 275 MG TAB has been published 163 times since Sep 9, 2020, and over the history we have for it it has declined 67.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2022 per EA
All-time high$0.6297 (Mar 10, 2021)
All-time low$0.1217 (Sep 18, 2024)
52-week high$0.3039
52-week low$0.1722
Median price$0.2031
Average price$0.2778
Largest weekly change-65.4% (Apr 17, 2024)
Weeks tracked163
Tracking sinceSep 9, 2020

Price History

1W

+3.1%

1M

+2.2%

3M

+6.4%

6M

-0.4%

1Y

-39.6%

3Y

-67.9%

5Y

-67.9%

All

-67.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NAPROXEN SODIUM 275 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN SODIUM 275 MG TAB, manufactured by ScieGen Pharmaceuticals, Inc., is $0.2022 per EA (NDC 50228043205), effective Nov 18, 2026.

How has the price of NAPROXEN SODIUM 275 MG TAB changed over time?

Over the history we have for it, the NADAC for NAPROXEN SODIUM 275 MG TAB has declined 67.9%. It has been tracked across 163 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for NAPROXEN SODIUM 275 MG TAB?

Since Sep 9, 2020, the NADAC for NAPROXEN SODIUM 275 MG TAB has ranged from a low of $0.1217 (Sep 18, 2024) to a high of $0.6297 (Mar 10, 2021), with a median of $0.2031 per EA.

Are there cheaper alternatives to NAPROXEN SODIUM 275 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NAPROXEN SODIUM 275 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures NAPROXEN SODIUM 275 MG TAB?

NAPROXEN SODIUM 275 MG TAB (NDC 50228043205) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.